A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancer.
Schwartzberg LS, Yee LK, Senecal FM, et al.
Oncologist 2004;9(6):696-707.
Review by
Prognostic significance of perioperative blood transfusion in oral cavity squamous cell carcinoma.
Taniguchi Y, Okura M
Head Neck 2003;25(11):931-936.
Review by
Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study.
Hedenus M, Adriansson M, Miguel JS, et al.
Br J Haematol 2003;122(3):394-403.
Review by
Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production.
Cazzola M, Beguin Y, Kloczko J, Spicka I, Coiffier B
Br J Haematol 2003;122(3):386-393.
Review by
Response predicting factors to recombinant human erythropoietin in cancer patients undergoing platinum-based chemotherapy.
This is a well done study of anemic cancer patients on cisplatin chemotherapy that documents nicely that the best predictor of an ultimate good response... Read More
Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy.
Vansteenkiste J, Pirker R, Massuti B, et al.
J Natl Cancer Inst 2002;94(16):1211-1220.
Review by Ford PA
Bleeding from endometrial and vaginal malignant tumors treated with activated recombinant factor VII.
Sajdak S, Moszynski R, Opala T
Eur J Gynaecol Oncol 2002;23(4):325-326.
Review by
Place of normovolemic hemodilution in oncologic cervicofacial and ENT surgery. [Article in French]
Boussofara M, Damak R, Bracco D, Ravussin P
Ann Fr Anesth Reanim 2002;21(4):271-275.
Review by Van der Linden P